536565 — Novelix Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹1.91bn
- IN₹1.83bn
- IN₹1.32bn
Annual cashflow statement for Novelix Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
R2022 March 31st | R2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | PRESS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -15.7 | -0.585 | 0.213 | 1.23 | 34 |
| Depreciation | |||||
| Non-Cash Items | 9.68 | -5.16 | -3.07 | -0.16 | -0.326 |
| Extraordinary Items | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 11.2 | -18.9 | -0.955 | -138 | -259 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 5.93 | -24.1 | -3.43 | -137 | -224 |
| Capital Expenditures | -18.6 | -0.044 | — | -1.06 | -32.6 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 21.4 | 0.795 | 1.87 | 30.4 | 15.3 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 2.75 | 0.751 | 1.87 | 29.3 | -17.2 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0 | — | — | 113 | 264 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 8.68 | -23.3 | -1.57 | 5.61 | 22.8 |